Scavenger Receptor BI Induced by HDL From Coronary Heart Disease May Be Related to Atherosclerosis

被引:3
|
作者
Gao, Fen [1 ]
Feng, Gao-jie [1 ]
Li, Hong [1 ]
Qin, Wei-wei [1 ]
Xiao, Chuan-shi [2 ]
机构
[1] Shanxi Med Univ, Dept Cardiol, Affiliated Hosp 2, 382 Wu Yi St, Taiyuan 030001, Peoples R China
[2] Shanxi Med Univ, Dept Cardiol, Affiliated Hosp 1, Taiyuan, Peoples R China
关键词
scavenger receptor BI; dysfunctional HDL; atherosclerosis; reverse cholesterol transport; coronary heart disease; DYSFUNCTIONAL HDL; CHOLESTEROL; VARIANT;
D O I
10.1177/10760296211029710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study aims to determine whether dysfunctional High Density Lipoprotein (HDL) influenced the expression of scavenger receptor class B type I (SR-B1) to determine reverse cholesterol transport. Blood samples obtained from coronary heart disease patients confirmed by angiography were collected. HDL was extracted from the blood via ultracentrifugation. Then, the HDL was injected into apoE-/- mice, and the HepG2 cells cultured with Dulbecco's modified eagle medium (DMEM) were added the HDL extracted from coronary heart disease patients. As controls, normal cases without coronary heart disease (CHD) and patients with angina pectoris and acute myocardial infarction were used. The protein expression levels of SR-B1 were detected by western blot, and the lipid accumulation levels were detected by Oil Red O staining in both tissues and cell levels. These results revealed that the HDL obtained from CHD patients downregulate the SR-B1 expression in ex vitro and in vitro studies. In addition, dysfunctional HDL may result in lower SR-B1 expression levels. The degree of SR-B1 expression levels could be relative to the degree of coronary congestion. Along with the increase in severe coronary congestion, such as myocardial infarction, the SR-B1 expression levels were lower. The dysfunctional HDL derived from coronary heart disease patients decreased the expression of SR-B1, and promoted lipid accumulation.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Infections, atherosclerosis, and coronary heart disease
    Pothineni, Naga Venkata K.
    Subramany, Swathi
    Kuriakose, Kevin
    Shirazi, Lily F.
    Romeo, Francesco
    Shah, Prediman K.
    Mehta, Jawahar L.
    EUROPEAN HEART JOURNAL, 2017, 38 (43) : 3195 - 3201B
  • [32] Lycopene, atherosclerosis, and coronary heart disease
    Rissanen, T
    Voutilainen, S
    Nyyssonen, K
    Salonen, JT
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (10) : 900 - 907
  • [33] ATHEROSCLEROSIS AND CORONARY HEART-DISEASE
    SCHETTLER, G
    HABENICHT, AJR
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (8A): : 948 - 951
  • [34] ATHEROSCLEROSIS AND CORONARY HEART-DISEASE
    ROBBSMITH, AHT
    LANCET, 1960, 2 (NOV5): : 1028 - 1029
  • [35] LIPOPROTEINS, CORONARY HEART DISEASE, AND ATHEROSCLEROSIS
    GOFMAN, JW
    GLAZIER, F
    TAMPLIN, A
    STRISOWER, B
    DELALLA, O
    PHYSIOLOGICAL REVIEWS, 1954, 34 (03) : 589 - 607
  • [36] ATHEROSCLEROSIS AND CORONARY HEART-DISEASE
    NEWMAN, M
    LANCET, 1960, 2 (OCT22): : 927 - 927
  • [37] ATHEROSCLEROSIS AND CORONARY HEART-DISEASE
    ACHESON, RM
    LANCET, 1960, 2 (SEP24): : 706 - 706
  • [38] PATHOGENESIS OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE
    DOYLE, JT
    MEDICAL COLLEGE OF VIRGINIA QUARTERLY, 1966, 2 (03): : 189 - &
  • [39] ATHEROSCLEROSIS AND CORONARY HEART-DISEASE
    GORDON, I
    LANCET, 1960, 2 (SEP10): : 602 - 602
  • [40] ATHEROSCLEROSIS AND CORONARY HEART-DISEASE
    LAURIE, W
    WOODS, JD
    LANCET, 1961, 1 (716): : 107 - &